大洋集团(01991.HK)拟按“2供1”供股筹集最多6098万港元
格隆汇5月13日丨大洋集团(01991.HK)发布公告,公司建议透过供股筹集最多约6098万港元(扣除专业费用及其他相关开支前),据此,435,589,000股供股股份将按“2供1”供股股份的基准配发及发行。认购价为每股供股股份0.14港元,认购价较股份于最后交易日在联交所所报的收市价每股0.18港元折让约22.22%。
假设公司于记录日期或的前并无发行及╱或购回新股份,总数435,589,000股供股股份将予配发及发行,相当于公司于本公告日期现有已发行股份约50.0%及经发行供股股份扩大后公司现有已发行股份约33.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.